Access cutting-edge sarcoma treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access sarcoma specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sarcoma treatment provided free
AdAPT-001 is an oncolytic virus that is injected directly into the tumor or via intraarterial administration. The purpose of this study is to find out if AdAPT-001 is safe and tolerable. The next step is to find out if AdAPT-001 if efficacious with or without a checkpoint inhibitor.
Sponsor: EpicentRx, Inc.
Check if you qualify for this sarcoma clinical trial in Houston, TX
If you're searching for sarcoma treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.